Bionexus Gene Lab Stock Volatility
| BGLC Stock | USD 5.10 1.53 23.08% |
BioNexus Gene is extremely dangerous given 3 months investment horizon. BioNexus Gene Lab secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of risk over the last 3 months. We were able to break down and interpolate thirty different technical indicators, which can help you to evaluate if expected returns of 3.85% are justified by taking the suggested risk. Use BioNexus Gene Downside Deviation of 10.44, mean deviation of 12.45, and Risk Adjusted Performance of 0.1154 to evaluate company specific risk that cannot be diversified away. Key indicators related to BioNexus Gene's volatility include:
90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
BioNexus Gene Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of BioNexus daily returns, and it is calculated using variance and standard deviation. We also use BioNexus's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of BioNexus Gene volatility.
ESG Sustainability
While most ESG disclosures are voluntary, BioNexus Gene's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to BioNexus Gene's managers and investors.Environmental | Governance | Social |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as BioNexus Gene can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of BioNexus Gene at lower prices to lower their average cost per share. Similarly, when the prices of BioNexus Gene's stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving together with BioNexus Stock
Moving against BioNexus Stock
BioNexus Gene Market Sensitivity And Downside Risk
BioNexus Gene's beta coefficient measures the volatility of BioNexus stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents BioNexus stock's returns against your selected market. In other words, BioNexus Gene's beta of 6.36 provides an investor with an approximation of how much risk BioNexus Gene stock can potentially add to one of your existing portfolios. BioNexus Gene Lab is showing large volatility of returns over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure BioNexus Gene's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact BioNexus Gene's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze BioNexus Gene Lab Demand TrendCheck current 90 days BioNexus Gene correlation with market (Dow Jones Industrial)BioNexus Beta |
BioNexus standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 35.26 |
It is essential to understand the difference between upside risk (as represented by BioNexus Gene's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of BioNexus Gene's daily returns or price. Since the actual investment returns on holding a position in bionexus stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in BioNexus Gene.
BioNexus Gene Lab Stock Volatility Analysis
Volatility refers to the frequency at which BioNexus Gene stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with BioNexus Gene's price changes. Investors will then calculate the volatility of BioNexus Gene's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of BioNexus Gene's volatility:
Historical Volatility
This type of stock volatility measures BioNexus Gene's fluctuations based on previous trends. It's commonly used to predict BioNexus Gene's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for BioNexus Gene's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on BioNexus Gene's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. BioNexus Gene Lab Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
BioNexus Gene Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 6.3634 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, BioNexus Gene will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BioNexus Gene or Chemicals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BioNexus Gene's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BioNexus stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
BioNexus Gene Lab has an alpha of 3.0559, implying that it can generate a 3.06 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a BioNexus Gene Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.BioNexus Gene Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of BioNexus Gene is 917.03. The daily returns are distributed with a variance of 1243.38 and standard deviation of 35.26. The mean deviation of BioNexus Gene Lab is currently at 12.74. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.93
α | Alpha over Dow Jones | 3.06 | |
β | Beta against Dow Jones | 6.36 | |
σ | Overall volatility | 35.26 | |
Ir | Information ratio | 0.11 |
BioNexus Gene Stock Return Volatility
BioNexus Gene historical daily return volatility represents how much of BioNexus Gene stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 35.2616% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.8352% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About BioNexus Gene Volatility
Volatility is a rate at which the price of BioNexus Gene or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of BioNexus Gene may increase or decrease. In other words, similar to BioNexus's beta indicator, it measures the risk of BioNexus Gene and helps estimate the fluctuations that may happen in a short period of time. So if prices of BioNexus Gene fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 2 M | 1.4 M | |
| Market Cap | 5 M | 4.7 M |
BioNexus Gene's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on BioNexus Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much BioNexus Gene's price varies over time.
3 ways to utilize BioNexus Gene's volatility to invest better
Higher BioNexus Gene's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of BioNexus Gene Lab stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. BioNexus Gene Lab stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of BioNexus Gene Lab investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in BioNexus Gene's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of BioNexus Gene's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
BioNexus Gene Investment Opportunity
BioNexus Gene Lab has a volatility of 35.26 and is 41.98 times more volatile than Dow Jones Industrial. 96 percent of all equities and portfolios are less risky than BioNexus Gene. You can use BioNexus Gene Lab to protect your portfolios against small market fluctuations. The stock experiences a very speculative upward sentiment. Check odds of BioNexus Gene to be traded at $4.85 in 90 days.Average diversification
The correlation between BioNexus Gene Lab and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BioNexus Gene Lab and DJI in the same portfolio, assuming nothing else is changed.
BioNexus Gene Additional Risk Indicators
The analysis of BioNexus Gene's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in BioNexus Gene's investment and either accepting that risk or mitigating it. Along with some common measures of BioNexus Gene stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.1154 | |||
| Market Risk Adjusted Performance | 0.621 | |||
| Mean Deviation | 12.45 | |||
| Semi Deviation | 8.4 | |||
| Downside Deviation | 10.44 | |||
| Coefficient Of Variation | 884.27 | |||
| Standard Deviation | 34.47 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
BioNexus Gene Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
| Microsoft vs. BioNexus Gene | ||
| Dupont De vs. BioNexus Gene | ||
| GM vs. BioNexus Gene | ||
| Alphabet vs. BioNexus Gene | ||
| Citigroup vs. BioNexus Gene | ||
| Visa vs. BioNexus Gene | ||
| SentinelOne vs. BioNexus Gene | ||
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against BioNexus Gene as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. BioNexus Gene's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, BioNexus Gene's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to BioNexus Gene Lab.
Complementary Tools for BioNexus Stock analysis
When running BioNexus Gene's price analysis, check to measure BioNexus Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNexus Gene is operating at the current time. Most of BioNexus Gene's value examination focuses on studying past and present price action to predict the probability of BioNexus Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNexus Gene's price. Additionally, you may evaluate how the addition of BioNexus Gene to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |